Target intelligence / Profile preview

Testis expressed transcript, Y-linked 18 (TTTY18)

Target
TTTY18
Molecular classification
Long noncoding RNA (lncRNA), Non-protein coding RNA
01

Overview

Testis expressed transcript, Y-linked 18 (TTTY18) is a long noncoding RNA (lncRNA) located on the Y chromosome (Yp11.2), first annotated based on its expression in the testis, though its functional roles extend to other biological contexts[5][7]. It does not encode a protein but participates in the regulation of gene expression, especially in the context of environmental stress responses and cancer biology. Elevated TTTY18 expression is observed in certain cancers, particularly colorectal cancer, where it appears related to tumor progression marker profiles. Its expression is responsive to environmental pollutants and downregulated by anti-cancer phytochemicals like genistein. The mechanistic details of TTTY18 function are not fully established, and it is not currently classified as a druggable therapeutic target[5][1][3][7].

Other names
NCRNA00143non-protein coding RNA 143
02

Mechanism of action

Downregulation of TTTY18 by genistein is associated with reduced cell viability and migration in cancer cells, and reduced tumor marker expression, suggesting TTTY18 may be involved in oncogenic pathways affected by genistein

03

Biological functions

Regulation of gene expression at the transcriptional and post-transcriptional levelInvolved in the cellular response to environmental pollutantsImplicated in cancer biology, specifically in tumor progression and response to anti-cancer compoundsEvidence suggests a role in spermatogenesis or testis-specific gene regulationNo evidence of roles such as signal transduction, apoptosis, or immune response documented currently
04

Disease associations

Cancer (dysregulated expression is observed in certain cancers, including colorectal cancer)Interaction with tumor progression markers in colorectal cancer; possibly serves as a disease marker but not as a classical driver geneOther (possible involvement in cellular responses to environmental toxins)
05

Safety considerations

No specific safety concerns or therapeutic challenges documented, as TTTY18 is not an established therapeutic target
06

Interacting drugs

Genistein
07

Biomarkers

Elevated TTTY18 expression may serve as a marker of tumor progression in colorectal cancerNo established or widely used biomarkers for patient selection or therapeutic response monitoring

Beyond the preview

Go deeper on Testis expressed transcript, Y-linked 18 (TTTY18).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Testis expressed transcript, Y-linked 18 (TTTY18).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call